Herring WL, Cole A, Phelps CE, Jiao B. Value assessment and reimbursement of early treatment for prevention in chronic progressive diseases: are traditional approaches up to the task? Presented at the ISPOR 2024; May 7, 2024. Atlanta, GA.
Wolowacz S, Lloyd A, Doward L, Hawe E. Estimating health-state utility for economic models in clinical trials and real-world studies. Presented at the ISPOR 2024; May 5, 2024. Atlanta, GA.
Gnanasakthy A, Crawford R, Qin S, Rockwood N, Doward L. Advanced patient-reported outcomes. Presented at the ISPOR 2024; May 5, 2024.
Rao S, Forns J, Danysh HE, Calingaert B, Dempsey C, Aquilina T, Pathak S, Anthony MS, Layton JB. Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis in the United States. Presented at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) 2024; March 5, 2024. Lisbon, Portugal.
Garcia de Albeniz Martinez X. Analysis methods - casual inference. Presented at the National Academies Board on Health Sciences Policy; February 7, 2024.
Ghaswalla P, Carrico J, Hicks KA. The annual economic burden of respiratory syncytial virus in adults in the United States. Presented at the 2024 Biomedical Advanced Reseaerch and Development Authority George Risi Memorial Journal Club; January 22, 2024.
Earnshaw S, Paret K. The role of operations research in access to pharmaceuticals. Presented at the NC State Operations Research Seminar Series; January 22, 2024. Raleigh, NC.
Anthony MS, Crouse JR. Heterogeneity in plasma lipoprotein response to dietary fish oil. Presented at the 8th International Symposium on Atherosclerosis; October 1988. Rome, Italy.